Online Formulary
  • Using the Formulary
  • Therapeutic Sections
    • 1. Gastro-intestinal system
    • 2. Cardiovascular system
    • 3. Respiratory
    • 4. Nervous system
    • 5. Infection
    • 6. Endocrine system
    • 7. Genito-urinary system
    • 8. Immune System
    • 8. Malignant disease
    • 9. Blood and blood-forming organs
    • 9. Nutrition and metabolic disorders
    • 10. Musculoskeletal system
    • 11. Eye
    • 12. Ear
    • 12. Nose
    • 12. Oropharynx
    • 13. Skin
    • 14. Vaccines
    • 15. Anaesthesia
    • 16. Emergency Treatment of Poisoning
    • Palliative Care
    • Wound management products
    • Stoma products
    • Continence products
    • Borderline substances
    • General recommendations and information
    • Shared Care
  • Using the Formulary
  • Therapeutic Sections
    • 1. Gastro-intestinal system
    • 2. Cardiovascular system
    • 3. Respiratory
    • 4. Nervous system
    • 5. Infection
    • 6. Endocrine system
    • 7. Genito-urinary system
    • 8. Immune System
    • 8. Malignant disease
      • 8.2 Antibody responsive malignancy
      • 8.3 Carcinoid syndrome
      • 8.4 Cytotoxic responsive malignancy
      • 8.5 Hormone responsive malignancy
        • 8.5.1 Antineoplastic drugs
        • 8.5.2 Hormone responsive breast cancer
        • 8.5.3 Pituitary and hypothalamic hormones and analogues
          • 8.5.3.1 Anti-gonadotrophin-releasing hormones
          • 8.5.3.2 Somatostatin analogues
      • 8.6 Immunotherapy responsive malignancy
      • 8.7 Photodynamic therapy responsive malignancy
      • 8.8 Targeted therapy responsive malignancy
      • Local recommendations (Malignant disease)
    • 9. Blood and blood-forming organs
    • 9. Nutrition and metabolic disorders
    • 10. Musculoskeletal system
    • 11. Eye
    • 12. Ear
    • 12. Nose
    • 12. Oropharynx
    • 13. Skin
    • 14. Vaccines
    • 15. Anaesthesia
    • 16. Emergency Treatment of Poisoning
    • Palliative Care
    • Wound management products
    • Stoma products
    • Continence products
    • Borderline substances
    • General recommendations and information
    • Shared Care
  • Search
  • Feedback

Drug Status Key

  • On Formulary
  • Specialist Initiation

    On formulary but requires initiation by a specialist. 
    GPs may then take on maintenance prescribing - 
    Using the Formulary (eastkentformulary.nhs.uk)

  • Shared Care
  • Hospital Only
  • Not Recommended

Preferences

  • First Line
  • Second Line
  • Third Line
  • No Preference

8.5.3.2 Somatostatin analogues

Expand All / Expand All (incl. cost)

Lanreotide

NICE EMC

Lanreotide 30mg powder and solvent for suspension for injection vials

Pack Price
1 vial

Lanreotide 60mg/0.5ml solution for injection pre-filled syringes

Pack Price
1 pre-filled disposable injection £551.00

Lanreotide 90mg/0.5ml solution for injection pre-filled syringes

Pack Price
1 pre-filled disposable injection £736.00

Lanreotide 120mg/0.5ml solution for injection pre-filled syringes

Pack Price
1 pre-filled disposable injection £937.00

Octreotide

NICE EMC

Octreotide 50micrograms/1ml solution for injection vials

Pack Price
5 vial

Octreotide 100micrograms/1ml solution for injection vials

Pack Price
5 vial £32.65

Octreotide 500micrograms/1ml solution for injection vials

Pack Price
5 vial £158.25

Octreotide 1mg/5ml solution for injection vials

Pack Price
1 vial £65.00

Octreotide 10mg powder and solvent for suspension for injection vials

Pack Price
1 vial £549.71

Octreotide 20mg powder and solvent for suspension for injection vials

Pack Price
1 vial £799.33

Octreotide 30mg powder and solvent for suspension for injection vials

Pack Price
1 vial £998.41

Online Formulary by M.O.M. Systems

NICE guidance is available from https://www.nice.org.uk/guidance All rights reserved. Subject to Notice of rights.
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

© Copyright 2025